Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
37 results
- 3상모집 중· Nasal PolypsGSK5784283 (Felcorekibart)의 만성 비부비동염 코폴립 환자에서 위약 대비 효능 및 안전성 평가 연구
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
리드: GSK
- 3상모집 중· Influenza, Human65세 이상 성인의 인플루엔자 백신 효능 연구
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
리드: GSK
- 3상모집 중· Multiple Myeloma새로 진단된 다발성 골수종에 대한 벨란타맙 마포도틴 또는 다라투무맙과 보르테조밉, 레날리도마이드 및 덱사메타손의 병용
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
협력: GSK
- 3상모집 중· Pulmonary Disease, Chronic Obstructive중등도에서 매우 심한 COPD 환자에서 GSK5784283(펠코레키바트)의 위약 대비 효능 및 안전성 평가 (PERSIST COPD-1)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
리드: GSK
- 3상모집 중· Gastrointestinal Stromal Neoplasms미치료 전이성/절제불가능 위장관 간질종양 환자에서 벨자티닙을 이마티닙과 비교하는 연구 (StrateGIST Frontline)
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
리드: GSK
- 3상모집 중· Metabolic Dysfunction-associated Steatohepatitis대사기능장애 관련 지방간염(MASH)으로 인한 보상된 간경변이 있는 성인 환자에서 에피모스페르민의 안전성 및 유효성을 위약과 비교하는 연구
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
리드: GSK
- 3상모집 중· Metabolic Dysfunction-associated Steatohepatitis대사기능장애 관련 지방간염(MASH)으로 인한 보상성 간경변증이 있는 성인 참가자에서 Efimosfermin과 위약의 안전성 및 유효성을 조사하는 주요 임상 연구
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
리드: GSK
- 3상모집 중· Asthma6~11세 참가자를 대상으로 한 데페모키마브 연구
A Study of Depemokimab in Participants of 6 to 11 Years of Age
리드: GSK
- 3상모집 중· Ovarian Neoplasms백금 내성 난소암 환자에서 mocertatug rezetecan과 표준 치료의 비교 연구(BEHOLD-Ovarian01)
A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
리드: GSK
- 3상모집 중· Neoplasms, Endometrial자궁내막암 환자에서 모세르타투그 레제테칸과 화학요법 비교 연구
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
리드: GSK
- 3상모집 중· Measles15개월~6세 소아에서의 시험용 결합 홍역, 볼거리, 풍진 및 수두 백신 근육주사 투여의 면역반응 및 안전성 연구
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
리드: GSK
- 3상모집 중· Non-alcoholic Fatty Liver DiseaseA Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
리드: GSK
- 3상모집 중· Gastrointestinal NeoplasmsA Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
리드: GSK
- 3상모집 중· Refractory Chronic CoughA 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
리드: GSK
- 3상모집 중· Non-alcoholic Fatty Liver DiseaseA Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
리드: GSK
- 3상모집 중· Neoplasms, LungA Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
리드: GSK
- 3상모집 중· Plasmodium Vivax MalariaFocaL Mass Drug Administration for Vivax Malaria Elimination
협력: GSK
- 3상모집 중· Lung Diseases, InterstitialA Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
리드: GSK
- 3상모집 중· Stage III Ovarian CancerHeated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
협력: GSK
- 3상모집 중· Kidney Transplant Recipient Response to Shingrix VaccineShingrix in Renal Transplant Recipients
협력: GSK
- 3상모집 중· Primary Immune Thrombocytopenia (ITP)Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
협력: GSK
- 3상모집 중· Hypereosinophilic SyndromeDepemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
리드: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.